๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Acadia Healthcare Company, Inc. (ACHC)
NASDAQ: ACHC ยท Real-Time Price ยท USD
37.59
-0.35 (-0.92%)
Nov 18, 2026, 4:00 PM EST - Market closed
โ† View all transcripts

2026 Stephens Annual Investment Conference | NASH2026

Nov 18, 2026

Summary

2026 brought stronger operating execution, three consecutive full-year guidance increases, and improving balance-sheet performance. Sixteen new facilities are expected to contribute $60 million of incremental EBITDA in 2027, with legacy capacity, continuum expansion, and disciplined investment supporting further growth.

Raj Kumar
Healthcare Services Analyst, Stephens

All right, welcome everyone to day two of the 2026 Stephens annual investment conference, live and in person in Nashville. I'm Raj Kumar, Healthcare Services Analyst here at Stephens. Next up, we have Acadia Healthcare, a leading provider of behavioral health services spanning across acute inpatient and outpatient settings. Joining us today from Acadia are David Duckworth, Interim CFO, and Jason Plagman, Head of Investor Relations. I want to thank you both for joining us here today, and I think we'll jump right into the Q&A if that's all good with you.

David Duckworth
Interim CFO, Acadia Healthcare

Sounds good.

Raj Kumar
Healthcare Services Analyst, Stephens

Awesome. Yeah, maybe to kick off the conversation, David, you came back this year to kind of steer the ship right back in the right direction, and as we kind of think about maybe how you've seen this year play out from a milestone or results perspective relative to your internal expectations, how would you frame 2026?

David Duckworth
Interim CFO, Acadia Healthcare

Sure. Like I said earlier, thanks for hosting. Good to be back at this conference, and it is great to be talking about Acadia with everyone here today. We've had a really good 2026, made a lot of progress across various initiatives at the company, and what I would absolutely highlight is the operational expertise that the company has, and Debbie's the one, actually, you talk about steering the ship, she's the captain. She's the one steering the ship. She came back in January, and what we've seen throughout the year with the team that she has just built and refined in a lot of ways, and with the opportunity that we have had with significant capacity, new facilities added to the company, we are seeing strong performance. Let me maybe go into a little more detail. Had strong results in the third quarter.

We're pleased to raise our guidance for the full year for the third consecutive time, also seeing improvements in the balance sheet. Our leverage, our free cash flow has exceeded our expectations throughout the year. Some of the key operational drivers, as you think about just what we mean when we say operational execution has improved throughout the year, part of that is strengthening the team, having the right people in the right roles, because we've added so much capacity. We're in 40 different states and Puerto Rico. The way that we approach all of our local markets, the unique opportunities that we have there, it requires just having people that are knowledgeable on those markets, expertise around how to work with a JV partner, having the right functional leaders at our corporate office that support our facilities. So, we've strengthened the team.

We think that will have a continuing positive impact as we think about the long-term value creation opportunities that we have. We've refined the operating structure, in some cases eliminated middle layers of management in order to be faster and have quick decision-making, focus, oversight in terms of how we best support our facilities, and clear priorities. The company's had just a lot going on over the last several years, adding a lot of capacity, making various other investments. So, just having a team that's the right people in the right roles, having the right accountability and priorities, I think has been a big part of our ability to make progress this year and to be positioned the way we are now for ongoing progress going into next year.

Raj Kumar
Healthcare Services Analyst, Stephens

Got it. Yeah, I mean, speaking of next year, I know you guys haven't formally guided, but as we kind of think about some of the puts and takes and some of the operational momentum, maybe just kind of help us remind, as you go through your budgeting process, what are some of the key priorities for next year?

David Duckworth
Interim CFO, Acadia Healthcare

Yeah, we will provide our 2027 outlook, as you mentioned, on our 4Q call. That's what we normally do. We do feel, as I mentioned a minute ago, very good about the progress we made, some of our positioning going into next year. But without a full outlook yet, we have been providing some commentary around early expectations for the year. Most importantly, for about a year now, we have talked about the incremental earnings at our 16 new facilities that we've opened from 2023 to 2026. That's 2,000 beds in those new facilities. The company before some of that growth had about 10,000 beds. So, significant capacity. Those 16 facilities, I think, provide the most significant opportunity as we move through the next several years.

When we provided that $200 million incremental EBITDA opportunity about a year ago, we did not talk about the phasing of that, how much of that was expected to be realized by year. The reason we didn't go into detail, we had a lot that still needed to happen. We still needed to open new facilities. We needed to see the ones that were opened in 2025 make progress in terms of their licensing, payer contracting, other key steps. We feel like we have made a lot of progress this year. We've opened all of the facilities. We've gotten all of them through their accreditation surveys. We're in a better position with more visibility than we've had so far.

A tailwind going into next year, that we had talked about in our third quarter earnings release, is that we're now providing an incremental EBITDA number from those new facilities for 2027 of $60 million. That's $60 million of the $200 million, 15 of which has already been realized. We think we're in a great position to deliver on that $60 million incremental EBITDA going into next year. We'll provide more commentary on other items in February. The only item that we are viewing as a headwind is just out of period, directed payments that we received early in 2026 related to 2025. That's about $37 million. We actually have some upside as well on some of the directed payment program accruals that we've made this year for programs that haven't yet been finalized. That could come in ahead of what we're expecting.

More to come as we get back to everyone in February, but really pleased with the progress we've made and what we're seeing in those new facilities.

Raj Kumar
Healthcare Services Analyst, Stephens

Great. In your earlier comments, you spoke to streamlining kind of regional and corporate leadership. Maybe help us kind of illustrate where that's had the greatest impact in terms of maybe volume or even clinical quality or staffing. Just would be curious in terms of kind of what pillars that's kind of helped free up.

David Duckworth
Interim CFO, Acadia Healthcare

It is really every aspect of our operations. Certainly, occupancy and volume would be the key driver of our performance and growth. That can look different from one market to another, and it has a lot to do with the way we run our facility locally, the leadership team we have, the relationships that we have with our local referral sources, which can include the hospital systems locally, emergency rooms that see a lot of the patients that ultimately make their way to our facilities, and a lot of other referral sources locally. Occupancy growth and the team's ability to just problem solve, support our local leaders, and at the same time, we have to do a good job on the cost management side. As we see volume growth, staffing the facilities appropriately, but then also just continuing to improve what we do and finding efficiencies.

The teams had a, I think, a really good year of just operating from an occupancy and volume growth perspective, but also from the perspective of cost discipline and finding efficiencies and improvements across many different operational initiatives. Staffing is our biggest cost. In terms of opportunities, we are always looking at how can we improve, how can we retain our employees, recruit employees successfully, and at the same time manage that cost according to where we see our volume trends.

Raj Kumar
Healthcare Services Analyst, Stephens

Got it. Speaking of broader just operational recovery, there are different nodes and all these aspects, and they are always progressing and being optimized. I guess, what do you think you have progressed the furthest, and where does Acadia as an organization still have the most work to do still?

David Duckworth
Interim CFO, Acadia Healthcare

Well, I think the greatest progress we have made is getting the capacity added. It is not easy to navigate, and it depends on the market and the state. Some states are difficult to open a new facility. We feel like with the high level of acuity that we treat, it is a huge advantage for the company to have much needed acute psych beds in markets that were in need of a bed, and in markets where we have a strong joint venture partner that moved over, in many cases, moved over beds into our new joint venture facility that we have with our partner. So, the greatest progress that we have made is just getting that capacity added.

Now, that's also the greatest opportunity that we have, is seeing the earnings that we expect and the value that we expect, and just the strength in our platform that will come from getting those facilities opened, operating, being a much needed facility in their local markets. As we do that, as we grow in those facilities and in our legacy facilities, I think the other opportunity that we have is continue to lead the industry in terms of the platform and the focus on quality, technology, how we're running our facilities well, collaborating with our payers and other partners and others in the community.

We have an ongoing focus on that, and I think all of that, between the scale and the capacity and growing into that, and at the same time strengthening the platform with certain investments, I think we'll see a stronger, larger company, especially in our acute service line as we move forward.

Raj Kumar
Healthcare Services Analyst, Stephens

Got it. Maybe I'll pause to see if there's any questions from the audience. All right. Maybe, yeah, I want to focus on the legacy portfolio. Clearly, there's strong demand for behavioral health services, incremental capacity opportunities to bed additions in those existing facilities, or even those that remain below their kind of potential occupancy thresholds. Maybe could you parse out the kind of organic growth opportunity between the kind of higher performing facilities that could stand to benefit from bed additions, and then maybe those that are still remaining or that remain underutilized?

David Duckworth
Interim CFO, Acadia Healthcare

Yeah, I think there's opportunities in both of those groups. As we think about the new facilities, obviously, we've talked about that already. We will see those new facilities be a significant driver of volume growth for the next several years. We have a strong runway into the next, not only 2027, but we think the next several years for those facilities. The legacy facilities, so those that were open prior to 2023, a lot of those facilities have added beds. We've actually added, in addition to the 2,000 new facility beds, we've added over 1,000 beds to those existing facilities over the last several years. They have capacity from those new beds, and I would say they even have capacity just from the service program and even some that haven't performed all the way at expectations, as the company talked about a year or two ago.

A lot of those facilities have capacity. A lot of those legacy facilities, and there's about 47 or 48 of those in the acute service line, a lot of those facilities are operating at a higher occupancy, have already added programs to meet growth and the demand at the local level, and they're ready for additional investments. We'll continue to look at the right services to offer, and as we think about potential expansions at those that are at a higher occupancy, look at the right need and whether it's an adult program, an adolescent program, geriatric program, that's something that we have always looked at as we've grown, is what are the right services that are needed in the community? That's where you'll see us adding beds.

I think that the legacy facilities were volume growth for those facilities contributed more than 1% to our volume growth in the third quarter. We've had a good year in those facilities and think that they have the capacity and available beds to continue that.

Raj Kumar
Healthcare Services Analyst, Stephens

Maybe could you also help us frame, and I think you've spoken to 35%-40% occupancy is kind of the break-even threshold within any four walls. I guess, what's the occupancy threshold to maybe consider existing facility bed expansions, and are you doing that sooner rather than later? Just give it kind of where construction costs and the kind of macro is, or have you still maintained that kind of breakthrough threshold?

David Duckworth
Interim CFO, Acadia Healthcare

Yeah, the overall point where we consider an expansion, and we always want our facilities to be thinking ahead, even before they're at the occupancy, to be planning for someday, here's how we would do it on the campus or even within the building footprint that we have. A lot of our facilities kind of have an available or a planned unit that can be added efficiently. We want to be ready for those opportunities when they happen, but are generally looking at the 75%, certainly the 80% occupancy level. Facilities would normally be ready for an expansion at that point. A lot of our facilities have that potential over the next several years. We mentioned the capacity that's already there, but a lot of facilities are already ready to be planning on their next expansion.

That is typically, from a return on capital perspective, one of the best investments that we can make, because we have the business built out in terms of payer contracts and referral source relationships, and we have a cost structure already built at the facility to support that incremental volume. I think that will continue to be an opportunity for the company in general at that 75%-80% occupancy level, but it varies in terms of the facility. We are looking at other types of programs, not just adding beds, but how can we continue to invest in our existing markets?

Raj Kumar
Healthcare Services Analyst, Stephens

Got it. Speaking of other programs, I think, maybe as we think about the legacy portfolio and a potential node for growth, maybe looking at post-discharge services like PHP, IOP. I guess, how meaningful is that of a lever to long-term growth, and how would you characterize what inning that progress is in?

David Duckworth
Interim CFO, Acadia Healthcare

Well, it is important to the company from just a clinical and operational perspective for us to have a discharge plan and treatment pathways for our patients when they leave our inpatient treatment. We do see patients continue into one of our PHP, IOP, or outpatient programs as they leave our inpatient facilities. But I think it is an opportunity for the company, because today, that is probably at the low end of where we think it could be. The low end mid-single digits is where we would say a lot of our patients would continue with us into one of our other programs. We think that can be higher, and we are looking at and have a new leader actually to support the company's initiatives and service offerings within our existing markets.

We are in more markets today because of our capacity growth, so that is an opportunity that derives from being in more markets, is just being able to look at our service offerings, invest more in that continuum of care, making sure we have the programs and the leaders to run those programs, but then also just build out the number of patients that can go into those programs when they leave our inpatient care. I do think it is a source of long-term revenue growth for the company.

Raj Kumar
Healthcare Services Analyst, Stephens

Got it. I think you've already kind of answered this, but want to dive deeper. On the $60 million kind of incremental adjusted EBITDA in 2027 from the 16 ramping facilities, how much of that is largely occupancy versus still finding efficiencies from a staffing or administrative cost perspective?

David Duckworth
Interim CFO, Acadia Healthcare

Most of what we see in that new facility EBITDA growth, we would attribute to occupancy increases. The startup losses that we see in those new facilities is really a function of, not of one-time costs that we're incurring as we open a new facility, but more of a function of adding a cost structure as you think about a leadership team, the administrative team at the local level, and then the clinical team to help the facility open their first and second units. The losses are a function of not having the census and the payer contracts in place at the date of opening, but having a cost structure, which we start building the cost structure six months or more in advance of a facility opening.

What we see as the facility gets the payer contracting in place, goes through the accreditation survey, is that it can then start contracting with payers, building out its referral source relationships, and increasing its census. As that census grows, the occupancy grows, what we're seeing is we have revenue, and the incremental margin is significant because the cost structure's already built out, and the facility moves not only from losses towards break-even as the occupancy grows, but then as the occupancy continues to grow and the margin becomes positive, there's just incremental positive margin impacts throughout that occupancy growth. Occupancy is absolutely the key driver, but management of the cost as the occupancy grows is also just the focus and part of what we help our local facilities manage.

Raj Kumar
Healthcare Services Analyst, Stephens

Got it. Maybe parsing out between the non-JV, the wholly owned, and the JV kind of ramping facilities, should we be kind of thinking about the ramps being materially different, kind of thinking about having a JV partnership that's kind of an embedded referral partner channel? Are those kind of cohorts performing drastically differently? Is there a bigger lift to the wholly owned operations? Maybe help us kind of think about that more from that perspective.

David Duckworth
Interim CFO, Acadia Healthcare

Yeah. Just thinking back to a lot of our new facilities are with a joint venture partner, and even if you think about the four facilities we have opened in 2026, three of those are with some just really great joint venture partners that we are excited about, and only one of those is a de novo that we opened in August in Florida. What you mentioned is absolutely true. We do believe that our joint venture partners provide our facilities with a faster occupancy ramp opportunity.

There is still a lot of work to be done at a joint venture facility just to make sure that we are collaborating well with our joint venture partner, that we are integrated into their pathways for their patients, and that their physicians and others within the hospital system know our facility and know the services we provide, and to build the referral of patients from the various access points within the hospital system to our facility. We do think that that provides a significant opportunity for the company, not only for a faster ramp, but then growth opportunities with that partner.

Because we are partnering with leading providers within the markets we are in, and they see a lot of patients, and we think there is some potential long-term benefits to continue to grow as our partners grow and as the joint ventures mature.

Raj Kumar
Healthcare Services Analyst, Stephens

Got it. Maybe looking at some of the different segments, clearly acute inpatient is the largest part of the portfolio. Saw strong revenue growth and volume growth in the third quarter. Maybe help us parse out kind of how much of that is just a function of just general market growth with BH kind of often thought as being one of the stronger end markets from a demand perspective, and then maybe also just from a market share gain perspective as well.

David Duckworth
Interim CFO, Acadia Healthcare

The acute service line has had a great year, and it is the progress we have made on the older facilities and volume growth there, combined with the newer facilities. 7.5% volume growth for the acute service line has been great for the year. We do believe that some of that growth is just meeting the demand. Many markets, obviously, that we enter into with new beds, we feel like there is a significant bed need in those markets. We have helped to meet the demand that is there. We have also gained market share as we think about, especially with our joint venture partners. Many of those joint venture partners had psychiatric beds or even a freestanding facility that they have moved over to our new joint venture facility.

If you think about just the industry as a whole, and especially looking at some of those markets that we are in, there is a shift of beds being moved into Acadia. Some market share gains are absolutely part of our growth within the acute service line, along with just adding beds to meet the demand that is there.

Raj Kumar
Healthcare Services Analyst, Stephens

As we kind of think about referral channels, we kind of touched upon this a little earlier, but as we kind of think about your traditional ER channel, but then you also talked about community channels as well. Where are you seeing the most success, and has that mix changed kind of drastically, say, over the last five years, and are you finding success in more non-traditional referral streams?

David Duckworth
Interim CFO, Acadia Healthcare

The inquiry growth, and we track our inquiries as well as many other metrics around how people find their way to an Acadia facility, and the inquiry growth has been broad across those different referral sources. The mix has not changed significantly. I think the hospital and ERs continues to be the main referral source, and that continues to grow. It is a diversified referral source if you look at other ways people find our facilities. We have seen good growth and stability across those referral sources.

Raj Kumar
Healthcare Services Analyst, Stephens

Got it.

Speaker 3

Can you talk about any changes in payer mix and how that might impact our Medicaid work requirements next year? That is actually going to happen now, or how that works?

David Duckworth
Interim CFO, Acadia Healthcare

Yep. Okay, the first question on payer mix. Our payer mix has been stable. Medicaid continues to be one of our larger payers and is part of each of our service lines. It can vary some by service line, but Medicaid continues to be our largest payer. The only payer that has changed slightly on a year-over-year basis is our commercial business. If you look at our percentage of revenue, it has gone from about 25% to 21%, but it is a function of some of our facility closures that we talked about last year.

We had a few specialty facilities that had a high level of commercial revenue closed. Other than that, commercial has been stable. We are in-network, take a long-term collaborative approach to our payers as we talk to them about our services and our outcomes and other initiatives. Feel like the payer mix at this point is stable.

In terms of your question on Medicaid, we believe the work requirements that are being rolled out, we are paying very close attention to those. It is now in the states to start implementing, although there is a little bit of a delay been made available to the states in how they do that, when they do that. But working with the states very closely, believe that it is not going to have a significant impact on our business as we look at the exemptions from those requirements and the patients that we treat. Do not believe that that will have a significant impact on the business, but continue to look at that, monitor that closely, and work with the states on how they implement that.

The main reason we do not expect that to be a significant impact, just the exemptions that are made available from a medical frailty perspective, and that would apply to patients with mental health and substance use disorders.

Raj Kumar
Healthcare Services Analyst, Stephens

As we kind of think about the broader portfolio, given the last couple years, there has been rationalization in a couple service lines, as specialties kind of one of them. As we kind of think about going into 2027, I know everything is under the lens, but do you feel kind of the portfolio remains steady and this is kind of the new baseline portfolio, or is there still more kind of rationalization to be expected?

David Duckworth
Interim CFO, Acadia Healthcare

We think the portfolio we have today is very strong and feel like each of our service lines represent strong diversification, continuum of care opportunities for the company, have great teams and facilities that are treating our patients across our different markets. So feel like today, we will always look at the portfolio and be able to adapt and revisit, but really pleased with the service lines and the facilities we have today. There, of course, was some closure that happened a year ago, but are really pleased with the outlook that we have across our different service lines and facilities.

Think that, in general, as we look at our existing markets, they provide stability and growth for the company as we are now in more markets, and we can continue to grow within our existing markets, across those service lines, and treat more patients, continue to meet the unmet demand that we think continues to be there in many of our markets. But it is a market-specific approach, and we are pleased with the platform we have and our ability to continue to grow within that.

Raj Kumar
Healthcare Services Analyst, Stephens

And maybe shifting to the CTC business. Last couple years, it has kind of been where capital has been deployed from an expansion standpoint through M&A or even de novos. But that business has kind of stabilized sequentially, and you have called out improving admission trends as you exited 3Q in September and entered 4Q in October with a much more efficient cost structure. I guess, what are the specific initiatives that are driving the improvement in admissions as we kind of think about the stability of that business and returning to a more normal growth baseline?

David Duckworth
Interim CFO, Acadia Healthcare

Yeah. We really continue to like the CTC service line, the diversification. It is a capital-light, stable business, and we think has very good opportunities moving forward. We are in 33 different states there and have a great team. We have made some changes to the team and how they work with our corporate leaders, how we approach really all aspects of that service to drive improvement. And we think where that can happen is the referrals of patients into that service line. We have made some adjustments to just make sure that at a local level, we are working within the community really the same way we do in a lot of our inpatient facilities to be able to treat more patients. And so some investment in just referral sources within the CTC service line and investments in patient retention.

Patients need to be in treatment for the long term, and there is a very long length of stay and ability to keep patients in treatment, and we think there is opportunity there, and that will be part of the volume improvement plan that we have in place. But the team has done a nice job this year just managing those different initiatives, stabilizing the business. Revenue has been stable sequentially, and we have talked about volumes improving the last couple months. So, think that business is on the right track, and some variability that we have seen as we have gone through this year from a market-specific perspective, but feel like it is in a good position and continue to stabilize. And we are still looking at markets that still need CTC clinics.

Raj Kumar
Healthcare Services Analyst, Stephens

All right. There has been policy dynamics where it expanded the scope of these services beyond the traditional clinical setting. I think Acadia primarily utilizes methadone as the treatment drug of choice. But as we kind of think about the greater availability of something like buprenorphine or other treatment alternatives, how does that kind of change the scope of the CTC business and Acadia's ability to just kind of adapt to that changing treatment pattern?

David Duckworth
Interim CFO, Acadia Healthcare

Yeah. I think one thing that's unique about Acadia is just our ability and our clinical resources and ability to work with all of our local physicians on managing a complex need and patient population that requires an individualized treatment plan. We do provide bup as well as methadone. It's a clinical decision based on what's right for that patient. Methadone has clinical abilities to just accommodate to more individualized needs of the patients from our perspective, and that's the reason it's 90% and bup is only about 10% on average. That product has been available now for many years, and so I feel like that's about where it has settled out in terms of our patient mix.

But methadone continues to be, and we think it'll continue to be the leader in terms of the medication use for the company just because of the need and what's right for the patients that we treat.

Raj Kumar
Healthcare Services Analyst, Stephens

Got it. Maybe as we come up on the final minutes here, would love to kind of get your thoughts on when investors debate the Acadia story, there's the general legal and regulatory kind of pen stroke work that's always kind of relevant in a government-dominated reimbursement stream, new facility execution, and/or the sustainability of kind of the operational improvements put into place in 2026. What do you kind of believe is the most underappreciated aspect to the earnings power of the business over the next three to five years?

David Duckworth
Interim CFO, Acadia Healthcare

Yeah. Well, I really believe the company is in a strong position with the capacity that we've added, our ability to treat patients across the continuum of care, especially just starting with high acuity options for patients, and then from there, the full continuum of care for mental health and substance use patients. So I really like the position we're in. In terms of what might be underappreciated in the story, the $200 million incremental EBITDA opportunity, I think the level of confidence and visibility we have into that with the progress we've made this year, it's starting to be, I think, better understood by investors. But our level of visibility into that, I think, is as strong as it's ever been, which positions us well to start delivering on a more significant piece of that going into next year.

The company, the free cash flow of the company has changed significantly from a year ago, where a lot of the strong operating cash flow that has always been a dynamic of our business is now not being reinvested into new facilities and startup losses, but available to the company to improve our balance sheet and have strong strategic flexibility moving forward. Those are two items that I think have changed significantly in the last year and put us in a good position going into next year.

Raj Kumar
Healthcare Services Analyst, Stephens

Great. As we kind of maybe one last one, as we kind of think about the capital allocation strategy, 2023 to 2026 were unique from a capacity expansion standpoint. How do you kind of feel about just, that is the portfolio that you kind of need to get up to or kind of get back running in shape before you kind of consider ramping up that capacity pipeline, as you kind of still have spoken to, there being a very great unmet demand, and a large part of that is just having the supply in place to service it?

David Duckworth
Interim CFO, Acadia Healthcare

Yeah, I think the acute service line and growing volumes into the capacity we have, and the fact that that provides several years of growth for the company. But even as we deliver on that growth, we will continue to invest, and I think it will be strengthening and expanding in the markets that we are in today, building new beds and programs across inpatient, outpatient, just to provide a more full continuum of care within our already strong markets, and having the strategic flexibility. We have always said that we are going to look at joint ventures, new facilities, CTC de novos, facility expansions at a market level, based on what is most attractive from a return perspective and what is in demand and most compelling within our existing market.

Our ability to do that and be flexible, I think, combined with a stronger free cash flow and balance sheet, puts us in a good position.

Raj Kumar
Healthcare Services Analyst, Stephens

Perfect. I think that brings us up at time. Thank you for being here with us.

David Duckworth
Interim CFO, Acadia Healthcare

Okay. Thank you.